Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

CKLife Sciences

WKN: 662762 / Symbol: CKLSF / Name: CKLife Sciences / Stock / Food & Tobacco / Small Cap /

€0.035
1.450%

0 0
0
0
Alimera Sciences

WKN: A0Q78Q / Symbol: ALIM / Name: Alimera Sciences / Stock / Pharmaceuticals / Small Cap /

?
9.190%

2 0
2
0
Anavex Life Sciences Corp

WKN: A1411S / Name: Anavex Life / Stock / Biotechnology & Medical Research / Small Cap /

€5.17
4.540%

0 0
0
0
WAVE Life Sciences Ltd

WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /

€5.35
4.670%

10 0
10
0
Growblox Sciences Inc

Name: Growblox Sciences Inc / Stock / Food & Tobacco / Micro Cap /

-
-

0 0
0
0
Kezar Life Sciences

WKN: A2JPE7 / Symbol: KZR / Name: Kezar Life Sciences / Stock / Biotechnology & Medical Research / Small Cap /

€0.52
-

7 0
7
0
Khiron Life Sciences Corp.

WKN: A2JMZC / Name: Khiron Life Sciences Corp. / Stock / ? /

€0.027
-24.830%

0 0
0
0
Vita Life Sciences Ltd.

WKN: A2DW3Z / Name: Vita Life Sciences Ltd. / Stock / ? /

€0.65
-1.530%

0 0
0
0
Gb Sciences Inc.

WKN: A2DP21 / Name: Gb Sciences Inc. / Stock / ? /

€0.005
150.000%

0 0
0
0
Tiziana Life Sciences plc

WKN: A1105W / Name: Tiziana Life / Stock / Collective Investments / Micro Cap /

€0.60
-3.250%

0 0
0
0
Atai Life Sciences B.v.

WKN: A3CSB4 / Name: Atai Life Sciences B.v. / Stock / ? /

€1.15
1.460%

0 0
0
0
Awakn Life Sciences Corp

WKN: A3CTL4 / Name: Awakn Life Sciences Corp / Stock / ? /

€0.043
-18.870%

0 0
0
0
Britannia Life Sciences Inc.

WKN: A3DACS / Name: Britannia Life Sciences Inc. / Stock / ? /

€0.012
-52.000%

0 0
0
0
Lexston Life Sciences Corp.

WKN: A3DNBV / Name: Lexston Life Sciences Corp. / Stock / ? /

€0.053
-

0 0
0
0
Xlife Sciences AG schließt den strategischen Reviewprozess per Q3 2024 ab
Xlife Sciences AG schließt den strategischen Reviewprozess per Q3 2024 ab
Xlife Sciences AG schließt den strategischen Reviewprozess per Q3 2024 ab
eqs_de 
0 03.09.24
Xlife Sciences AG: Erfolgreiches erstes Halbjahr 2024 mit strategischen Fortschritten und soliden Finanzkennzahlen
Xlife Sciences AG: Erfolgreiches erstes Halbjahr 2024 mit strategischen Fortschritten und soliden Finanzkennzahlen
Xlife Sciences AG: Erfolgreiches erstes Halbjahr 2024 mit strategischen Fortschritten und soliden Finanzkennzahlen
eqs_de 
0 19.09.24
Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures
Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures
Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures
eqs_en 
0 19.09.24